ETF Holdings Breakdown of SANA

Stock Name	Sana Biotechnology Inc
Ticker	SANA(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US7995661045

SANA institutional holdings

The following institutional investment holdings of SANA have been identified

Date ETF ISIN/Name Num Shares Book value
2025-10-17 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 29,678 USD 149,280

2025-10-17 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 165,241 USD 831,162

2025-10-17 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 165,241 USD 831,162

Total = 360,160 USD 1,811,604
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value
2025-10-17	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	29,678	USD 149,280
2025-10-17	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	165,241	USD 831,162
2025-10-17	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	165,241	USD 831,162
Total =	360,160	USD 1,811,604

News associated with SANA

Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Average Recommendation of “Buy” from Analysts: Shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report) have been given a consensus recommendation of “Buy” by the six research firms that are presently covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have updated their coverage on the […] - 2025-09-10 03:11:08
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Average Recommendation of “Buy” from Brokerages: Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report) has been assigned a consensus rating of “Buy” from the six ratings firms that are covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have updated their coverage on the […] - 2025-08-11 05:31:01
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Sold by TD Asset Management Inc: TD Asset Management Inc cut its stake in shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 23.6% in the 1st quarter, Holdings Channel.com reports. The firm owned 309,034 shares of the company’s stock after selling 95,314 shares during the period. TD Asset Management Inc’s holdings in Sana Biotechnology were worth $519,000 as of […] - 2025-08-05 04:37:19
JMP Securities Reaffirms Market Outperform Rating for Sana Biotechnology (NASDAQ:SANA): Sana Biotechnology (NASDAQ:SANA – Get Free Report)‘s stock had its “market outperform” rating reiterated by analysts at JMP Securities in a research note issued on Tuesday,Benzinga reports. They currently have a $5.00 price target on the stock. JMP Securities’ target price indicates a potential upside of 72.41% from the company’s previous close. Several other brokerages […] - 2025-06-26 03:13:02
Hsbc Holdings PLC Buys 19,084 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA): Hsbc Holdings PLC raised its stake in shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 140.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 32,704 shares of the company’s stock after purchasing an additional 19,084 shares during the period. Hsbc Holdings […] - 2025-05-13 05:06:58
Legal & General Group Plc Has $263,000 Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA): Legal & General Group Plc reduced its holdings in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 4.1% in the 4th quarter, HoldingsChannel reports. The fund owned 161,177 shares of the company’s stock after selling 6,823 shares during the period. Legal & General Group Plc’s holdings in Sana Biotechnology were worth $263,000 at the end […] - 2025-05-01 04:57:03
Sana Biotechnology, Inc. (NASDAQ:SANA) Stake Raised by ExodusPoint Capital Management LP: ExodusPoint Capital Management LP grew its holdings in shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 174.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 272,908 shares of the company’s stock after purchasing an additional 173,442 shares during […] - 2025-04-13 05:33:23
Teacher Retirement System of Texas Has $60,000 Position in Sana Biotechnology, Inc. (NASDAQ:SANA): Teacher Retirement System of Texas boosted its stake in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 20.3% in the fourth quarter, HoldingsChannel reports. The firm owned 36,797 shares of the company’s stock after buying an additional 6,209 shares during the period. Teacher Retirement System of Texas’ holdings in Sana Biotechnology were worth $60,000 as […] - 2025-04-03 04:16:48
Wednesday's ETF Movers: XBI, PICK: In trading on Wednesday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 2.7% on the day. Components of that ETF showing particular strength include shares of Scilex Holding, up about 28.8% and shares of Sana Biotechnology, up about 16% on the day. And under - 2025-04-02 13:28:39
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Acquired by Corient Private Wealth LLC: Corient Private Wealth LLC increased its position in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 161.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,182,699 shares of the company’s stock after purchasing an additional 730,699 shares during the period. Corient Private Wealth LLC owned 0.53% […] - 2025-03-25 05:53:07
HC Wainwright Reiterates Buy Rating for Sana Biotechnology (NASDAQ:SANA): Sana Biotechnology (NASDAQ:SANA – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a $11.00 price target on the stock. HC Wainwright’s target price indicates a potential upside of 370.09% from the company’s previous close. Several other brokerages also […] - 2025-03-20 04:28:49
Sana Biotechnology (NASDAQ:SANA) Upgraded at Citizens Jmp: Citizens Jmp upgraded shares of Sana Biotechnology (NASDAQ:SANA – Free Report) from a market perform rating to an outperform rating in a report issued on Tuesday, Marketbeat reports. They currently have $5.00 price target on the stock. A number of other equities research analysts have also recently issued reports on SANA. HC Wainwright boosted their […] - 2025-03-19 04:47:01
Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Rating of “Moderate Buy” by Brokerages: Shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven ratings firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The […] - 2025-03-19 04:06:50
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Acquired by China Universal Asset Management Co. Ltd.: China Universal Asset Management Co. Ltd. increased its stake in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 10.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 47,341 shares of the company’s stock after buying an additional 4,554 shares during the quarter. China […] - 2025-02-04 06:53:05

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.